{"id":"W2046941822","doi":"10.1002/ana.21079","title":"Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial","year":2007,"lang":"en","type":"article","venue":"Annals of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"McGill University; Wayne State University; Teva Pharmaceutical Industries; Yale University","keywords":"Glatiramer acetate; Expanded Disability Status Scale; Medicine; Hazard ratio; Confidence interval; Post-hoc analysis; Placebo; Discontinuation; Multiple sclerosis; Clinical endpoint; Internal medicine; Randomized controlled trial; Interim analysis; Physical therapy; Pathology; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00231587,0.0003044765,0.001363692,0.0007665994,0.00005962286,0.000008281334,0.0002611273,0.0002349061,0.00002411028],"category_scores_gemma":[0.005176657,0.0002527389,0.0003296071,0.000474587,0.0005708283,0.0001400937,0.0002338125,0.0005420497,0.000009406225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002232897,"about_ca_system_score_gemma":0.0001492445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001483081,"about_ca_topic_score_gemma":0.0001694774,"domain_scores_codex":[0.9957797,0.0003511671,0.001727655,0.0005949944,0.0007932291,0.0007532604],"domain_scores_gemma":[0.9947148,0.002810545,0.0008791044,0.0004738627,0.0009321648,0.0001895113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9512005,0.002655184,0.01193211,0.0001566814,0.0003448435,0.00007605536,0.0006195476,0.00006344156,0.02689812,0.00001168936,0.0004844328,0.005557421],"study_design_scores_gemma":[0.737579,0.003392872,0.2458443,0.0001559085,0.00004855253,0.000005670451,0.00005432843,0.00102064,0.01124666,0.000008937886,0.0005017927,0.0001413904],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869438,0.0008287767,0.00001317689,0.004695641,0.0002162191,0.005972852,0.00004815875,0.00003542889,0.001245877],"genre_scores_gemma":[0.9967706,0.0008467283,0.0006331401,0.001010003,0.000167644,0.0003854336,0.00005218383,0.00003483322,0.00009944943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2339122,"threshold_uncertainty_score":0.9999925,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1833088050088483,"score_gpt":0.3964704440488094,"score_spread":0.2131616390399611,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}